Xencor Inc
XNCR
ISIN null / Valor 22585567
Xencor Inc
UMushroom community rating:
About company
Xencor Inc is a biopharmaceutical company dedicated to developing antibody-based therapies for cancer and other serious diseases. Leveraging its proprietary XmAb® protein engineering platform, Xencor has established a diverse pipeline with over 20 drug candidates currently undergoing clinical testing and additional programs in preclinical stages. The company collaborates with various partners to commercialize its technologies, resulting in three XmAb medicines being marketed. Xencor’s focus on innovative protein engineering aims to enhance the effectiveness and safety of antibody drugs, positioning the company as a key player in the therapeutic antibody landscape.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
912 M
Market cap (USD)
874,816
Daily traded volume (Shares)
24.04 / 23.37
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
